[PHARMA] QoQ Annualized Quarter Result on 31-Dec-2018 [#4]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
21-Feb-2019
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2018
Quarter
31-Dec-2018 [#4]
Profit Trend
QoQ- -16.25%
YoY- -21.1%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
Revenue 2,806,462 2,775,996 3,144,432 2,384,956 2,384,416 2,401,304 2,471,692 8.82%
PBT 62,145 85,448 120,972 70,220 77,706 81,354 114,828 -33.56%
Tax -23,097 -27,628 -42,380 -26,990 -26,160 -34,644 -44,472 -35.36%
NP 39,048 57,820 78,592 43,230 51,546 46,710 70,356 -32.44%
-
NP to SH 39,172 57,796 78,468 42,468 50,708 45,960 70,344 -32.28%
-
Tax Rate 37.17% 32.33% 35.03% 38.44% 33.67% 42.58% 38.73% -
Total Cost 2,767,414 2,718,176 3,065,840 2,341,726 2,332,869 2,354,594 2,401,336 9.91%
-
Net Worth 516,387 518,564 528,825 509,862 522,618 519,642 524,838 -1.07%
Dividend
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
Div 29,557 44,299 62,521 41,621 48,535 46,767 51,964 -31.32%
Div Payout % 75.46% 76.65% 79.68% 98.01% 95.71% 101.76% 73.87% -
Equity
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
Net Worth 516,387 518,564 528,825 509,862 522,618 519,642 524,838 -1.07%
NOSH 261,229 261,229 260,505 260,505 260,505 259,821 259,821 0.36%
Ratio Analysis
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
NP Margin 1.39% 2.08% 2.50% 1.81% 2.16% 1.95% 2.85% -
ROE 7.59% 11.15% 14.84% 8.33% 9.70% 8.84% 13.40% -
Per Share
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
RPS 1,076.09 1,065.29 1,207.05 916.82 917.05 924.21 951.31 8.55%
EPS 15.01 22.18 30.12 16.33 19.51 17.68 27.08 -32.49%
DPS 11.33 17.00 24.00 16.00 18.67 18.00 20.00 -31.51%
NAPS 1.98 1.99 2.03 1.96 2.01 2.00 2.02 -1.32%
Adjusted Per Share Value based on latest NOSH - 260,505
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
RPS 194.73 192.61 218.18 165.48 165.44 166.61 171.50 8.82%
EPS 2.72 4.01 5.44 2.95 3.52 3.19 4.88 -32.24%
DPS 2.05 3.07 4.34 2.89 3.37 3.24 3.61 -31.40%
NAPS 0.3583 0.3598 0.3669 0.3538 0.3626 0.3606 0.3642 -1.08%
Price Multiplier on Financial Quarter End Date
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
Date 30/09/19 28/06/19 29/03/19 31/12/18 28/09/18 29/06/18 30/03/18 -
Price 2.44 2.84 2.27 2.78 2.89 2.88 4.28 -
P/RPS 0.23 0.27 0.19 0.30 0.32 0.31 0.45 -36.04%
P/EPS 16.25 12.80 7.54 17.03 14.82 16.28 15.81 1.84%
EY 6.16 7.81 13.27 5.87 6.75 6.14 6.33 -1.79%
DY 4.64 5.99 10.57 5.76 6.46 6.25 4.67 -0.42%
P/NAPS 1.23 1.43 1.12 1.42 1.44 1.44 2.12 -30.41%
Price Multiplier on Announcement Date
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
Date 20/11/19 23/08/19 16/05/19 21/02/19 19/11/18 17/08/18 16/05/18 -
Price 2.21 2.66 2.36 2.76 3.09 3.11 4.07 -
P/RPS 0.21 0.25 0.20 0.30 0.34 0.34 0.43 -37.95%
P/EPS 14.71 11.99 7.83 16.91 15.84 17.58 15.03 -1.42%
EY 6.80 8.34 12.76 5.92 6.31 5.69 6.65 1.49%
DY 5.13 6.39 10.17 5.80 6.04 5.79 4.91 2.96%
P/NAPS 1.12 1.34 1.16 1.41 1.54 1.56 2.01 -32.26%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment